Sale!

Immunophenotyping by Flow Cytometry CD22 Test

Original price was: $112.Current price is: $88.

-21%

The CD22 Immunophenotyping by Flow Cytometry Test is a sophisticated diagnostic tool that analyzes CD22 protein expression on blood cells to detect and monitor hematological malignancies. This advanced test provides crucial information for diagnosing B-cell lymphomas, leukemias, and other blood disorders. Using state-of-the-art flow cytometry technology, the test measures CD22 surface markers to identify abnormal cell populations and guide targeted treatment decisions. Results are available same-day when samples are received by 9 am. The test costs $88 USD and requires blood or bone marrow samples collected in specific tubes. This specialized analysis helps oncologists and hematologists develop personalized treatment strategies for patients with suspected or confirmed blood cancers.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CD22 Immunophenotyping by Flow Cytometry Test

Comprehensive Introduction to CD22 Flow Cytometry Testing

Immunophenotyping by Flow Cytometry CD22 Test represents a cutting-edge diagnostic approach in modern hematology and oncology. This sophisticated laboratory analysis provides critical insights into the expression patterns of CD22, a crucial B-cell surface antigen that plays a significant role in immune system regulation and hematological malignancies. The test utilizes advanced flow cytometry technology to precisely quantify and characterize CD22 expression on various cell populations, offering invaluable information for diagnosis, classification, and treatment monitoring of blood cancers.

What the CD22 Test Measures and Detects

The CD22 Immunophenotyping test specifically measures the presence and density of CD22 antigens on the surface of blood cells. CD22 is a transmembrane glycoprotein primarily expressed on mature B-cells and serves as an important marker for:

  • B-cell lineage identification and characterization
  • Detection of abnormal B-cell populations in leukemia and lymphoma
  • Monitoring treatment response in B-cell malignancies
  • Assessing minimal residual disease after therapy
  • Differentiating between various types of B-cell disorders

Clinical Applications and Detection Capabilities

This advanced diagnostic tool can detect subtle abnormalities in CD22 expression patterns that may indicate the presence of hematological malignancies. The test provides quantitative data on CD22 density and distribution across different cell populations, enabling precise characterization of B-cell disorders and guiding targeted therapeutic interventions.

Who Should Consider CD22 Immunophenotyping Testing

This specialized test is recommended for individuals presenting with symptoms or clinical findings suggestive of hematological disorders, including:

  • Patients with unexplained lymphadenopathy or enlarged lymph nodes
  • Individuals experiencing persistent fatigue, fever, or night sweats
  • Patients with abnormal complete blood count (CBC) results
  • Those with suspected or confirmed B-cell leukemia or lymphoma
  • Individuals requiring treatment monitoring for existing hematological malignancies
  • Patients with autoimmune disorders affecting B-cell function
  • Those undergoing evaluation for bone marrow transplantation

Symptoms and Clinical Indications

Specific clinical scenarios that warrant CD22 testing include unexplained weight loss, recurrent infections, bone pain, hepatosplenomegaly, and abnormal bleeding or bruising patterns. The test is particularly valuable when conventional diagnostic methods provide inconclusive results or when precise characterization of B-cell disorders is required for treatment planning.

Significant Benefits of CD22 Flow Cytometry Testing

Choosing the CD22 Immunophenotyping test offers numerous advantages for patients and healthcare providers:

  • Precise Diagnosis: Provides accurate identification and classification of B-cell malignancies
  • Treatment Guidance: Helps oncologists select appropriate targeted therapies
  • Rapid Results: Same-day reporting when samples are received by 9 am
  • Minimal Sample Requirement: Requires only small blood or bone marrow volumes
  • Comprehensive Analysis: Offers detailed characterization of cell populations
  • Monitoring Capability: Enables effective tracking of treatment response
  • Cost-Effective: Affordable testing with significant clinical value

Understanding Your CD22 Test Results

Interpreting CD22 immunophenotyping results requires specialized expertise, but general guidance includes:

  • Normal CD22 Expression: Typically indicates healthy B-cell populations
  • Abnormal CD22 Patterns: May suggest B-cell malignancies or disorders
  • Quantitative Variations: Changes in CD22 density can indicate disease progression
  • Population Distribution: Abnormal distribution patterns may reveal specific disorders

Clinical Correlation and Follow-up

Your healthcare provider will correlate CD22 results with clinical findings, other laboratory tests, and imaging studies to establish a comprehensive diagnosis. Abnormal results typically warrant further evaluation and may lead to additional specialized testing or treatment initiation.

Test Pricing and Sample Requirements

Price Type Amount (USD)
Discount Price $88
Regular Price $112

Sample Collection and Processing

Turnaround Time: Sample Daily by 9 am; Report Same day

Sample Requirements: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube AND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube.

Shipping Instructions: Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on test request form.

Pre-test Instructions: Provide brief clinical history for accurate interpretation.

Nationwide Testing Availability

We have branches across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, Milwaukee, Albuquerque, Tucson, Fresno, Sacramento, Kansas City, Long Beach, Mesa, Atlanta, Colorado Springs, Virginia Beach, Raleigh, Omaha, Miami, Oakland, Minneapolis, Tulsa, Wichita, New Orleans, and Arlington.

Book Your CD22 Immunophenotyping Test Today

Take the first step toward precise diagnosis and effective treatment planning. Our specialized flow cytometry testing provides the critical information your healthcare team needs to make informed decisions about your care. Contact us now to schedule your CD22 immunophenotyping test and benefit from our same-day reporting capability.

Call or WhatsApp: +1(267) 388-9828

Our experienced team is ready to assist you with test scheduling, sample collection guidance, and result interpretation. Trust General Genetics Corporation for advanced diagnostic testing that makes a difference in your healthcare journey.